Product Code: ETC7637215 | Publication Date: Sep 2024 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Ireland Pertussis Market refers to the market for the diagnosis, treatment, and prevention of pertussis, also known as whooping cough, in Ireland. Pertussis is a highly contagious respiratory disease that can be particularly severe in infants and young children. The market includes various diagnostic tests, such as polymerase chain reaction (PCR) and serology, as well as vaccines for prevention, such as the combination vaccine DTaP. The market is influenced by factors such as the incidence of pertussis cases, vaccination rates, government healthcare policies, and public awareness campaigns. Key players in the Ireland Pertussis Market include pharmaceutical companies manufacturing vaccines, diagnostic companies producing testing kits, healthcare providers, and public health authorities working towards controlling the spread of the disease. Ongoing research and development efforts aim to improve diagnostic techniques and develop more effective vaccines to combat pertussis in Ireland.
In the Ireland Pertussis Market, there is a growing focus on increased vaccination rates to prevent the spread of whooping cough, especially among infants and pregnant women. The demand for pertussis vaccines has been steadily increasing due to the rising awareness about the importance of immunization in preventing this highly contagious respiratory infection. Additionally, there is a trend towards the development of more effective and long-lasting vaccines to provide better protection against pertussis. Pharmaceutical companies are investing in research and development to improve vaccine formulations and delivery methods, with an emphasis on safety and efficacy. The market also shows a shift towards public health initiatives promoting vaccination campaigns and education to combat the resurgence of pertussis cases in Ireland.
In the Ireland Pertussis Market, some of the key challenges include limited awareness among the general population about the importance of pertussis vaccination, leading to lower vaccination rates. Additionally, there may be issues related to access to healthcare services in certain regions, which could hinder timely diagnosis and treatment of pertussis cases. Another challenge is the possibility of vaccine hesitancy among some individuals or communities, which can impact the overall effectiveness of pertussis prevention efforts. Moreover, the evolving nature of the Bordetella pertussis bacterium and the potential for waning immunity over time present ongoing challenges in maintaining high levels of protection against pertussis in the population. Addressing these challenges will require coordinated efforts from healthcare providers, policymakers, and public health authorities to ensure effective prevention and control of pertussis in Ireland.
The Ireland Pertussis Market presents several investment opportunities across various sectors. Pharmaceutical companies focusing on developing new vaccines or improving existing ones for pertussis prevention could benefit from the increasing demand for effective immunization solutions. Biotechnology firms specializing in diagnostic tools for rapid and accurate pertussis detection also hold promise in the market. Furthermore, healthcare providers offering vaccination services and healthcare facilities investing in advanced treatment options for pertussis patients could see growth opportunities. Additionally, research institutions focusing on studying the epidemiology and treatment outcomes of pertussis in Ireland could attract funding for innovative projects. Overall, investing in the Ireland Pertussis Market offers diverse avenues for growth and innovation within the healthcare and life sciences industries.
Government policies related to the Ireland Pertussis Market primarily focus on vaccination programs to prevent the spread of pertussis, also known as whooping cough. The Health Service Executive (HSE) in Ireland recommends the pertussis vaccine for infants, children, pregnant women, and healthcare workers to protect vulnerable populations from the disease. The National Immunisation Advisory Committee (NIAC) provides guidance on the use of pertussis vaccines and updates vaccination schedules as needed. Additionally, the Department of Health monitors pertussis outbreaks, conducts awareness campaigns, and ensures the availability and accessibility of vaccines across the country. These policies aim to reduce the incidence of pertussis, minimize its impact on public health, and ultimately contribute to a healthier population in Ireland.
The Ireland Pertussis market is expected to witness steady growth in the coming years due to increasing awareness about the importance of vaccination and the rising incidence of pertussis cases. The introduction of new and improved vaccines, along with government initiatives to promote immunization, are likely to drive the market growth. Additionally, the growing focus on preventive healthcare measures and the rising healthcare expenditure will contribute to the market expansion. However, challenges such as vaccine hesitancy and supply chain disruptions may hinder market growth to some extent. Overall, the Ireland Pertussis market is poised for growth, with opportunities for market players to innovate and develop effective solutions to combat pertussis effectively.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Pertussis Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Pertussis Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Pertussis Market - Industry Life Cycle |
3.4 Ireland Pertussis Market - Porter's Five Forces |
3.5 Ireland Pertussis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Ireland Pertussis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Ireland Pertussis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Pertussis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Ireland Pertussis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Pertussis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Ireland Pertussis Market Trends |
6 Ireland Pertussis Market, By Types |
6.1 Ireland Pertussis Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Ireland Pertussis Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Ireland Pertussis Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.1.4 Ireland Pertussis Market Revenues & Volume, By Chest X-Ray, 2021- 2031F |
6.1.5 Ireland Pertussis Market Revenues & Volume, By Nose or Throat Culture & Test, 2021- 2031F |
6.1.6 Ireland Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Pertussis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Ireland Pertussis Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Ireland Pertussis Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.2.4 Ireland Pertussis Market Revenues & Volume, By Supportive Treatments, 2021- 2031F |
6.2.5 Ireland Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Pertussis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Pertussis Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Ireland Pertussis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Ireland Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Pertussis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Pertussis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Ireland Pertussis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Ireland Pertussis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Ireland Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Pertussis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Pertussis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Ireland Pertussis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Ireland Pertussis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Ireland Pertussis Market Import-Export Trade Statistics |
7.1 Ireland Pertussis Market Export to Major Countries |
7.2 Ireland Pertussis Market Imports from Major Countries |
8 Ireland Pertussis Market Key Performance Indicators |
9 Ireland Pertussis Market - Opportunity Assessment |
9.1 Ireland Pertussis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Ireland Pertussis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Ireland Pertussis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Pertussis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Ireland Pertussis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Pertussis Market - Competitive Landscape |
10.1 Ireland Pertussis Market Revenue Share, By Companies, 2024 |
10.2 Ireland Pertussis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |